HighPoint Advisor Group’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $552K | Buy |
6,023
+2
| +0% | +$175 | 0.02% | 445 |
|
|
2026
Q1 | $513K | Sell |
6,021
-15,887
| -73% | -$1.42M | 0.02% | 418 |
|
|
2025
Q4 | $1.73M | Buy |
21,908
+6,140
| +39% | +$481K | 0.04% | 343 |
|
|
2025
Q3 | $1.26M | Sell |
15,768
-739
| -4% | -$63K | 0.06% | 222 |
|
|
2025
Q2 | $1.5M | Buy |
16,507
+144
| +0.9% | +$13.1K | 0.08% | 193 |
|
|
2025
Q1 | $1.51M | Buy |
16,363
+33
| +0.2% | +$2.96K | 0.09% | 184 |
|
|
2024
Q4 | $1.43M | Buy |
16,330
+672
| +4% | +$64.1K | 0.08% | 194 |
|
|
2024
Q3 | $1.46M | Sell |
15,658
-495
| -3% | -$50.5K | 0.09% | 185 |
|
|
2024
Q2 | $1.62M | Buy |
16,153
+497
| +3% | +$45.8K | 0.1% | 164 |
|
|
2024
Q1 | $1.48M | Sell |
15,656
-314
| -2% | -$26.6K | 0.1% | 155 |
|
|
2023
Q4 | $1.42M | Buy |
+15,970
| New | +$1.2M | 0.1% | 159 |
|
|
2022
Q2 | $1.21M | Buy |
+14,977
| New | +$1.17M | 0.13% | 126 |
|
|
2021
Q3 | $1.09M | Sell |
14,378
-10,581
| -42% | -$840K | 0.11% | 152 |
|
|
2021
Q2 | $2.03M | Buy |
24,959
+10,325
| +71% | +$844K | 0.2% | 97 |
|
|
2021
Q1 | $1.17M | Buy |
14,634
+114
| +0.8% | +$8.94K | 0.14% | 129 |
|
|
2020
Q4 | $1.14M | Buy |
14,520
+2,354
| +19% | +$195K | 0.14% | 127 |
|
|
2020
Q3 | $1.01M | Buy |
12,166
+56
| +0.5% | +$4.27K | 0.18% | 105 |
|
|
2020
Q2 | $884K | Buy |
12,110
+510
| +4% | +$36.2K | 0.19% | 99 |
|
|
2020
Q1 | $828K | Buy |
11,600
+326
| +3% | +$23K | 0.2% | 96 |
|
|
2019
Q4 | $803K | Buy |
11,274
+305
| +3% | +$20.8K | 0.17% | 113 |
|
|
2019
Q3 | $730K | Buy |
10,969
+3,367
| +44% | +$244K | 0.16% | 114 |
|
|
2019
Q2 | $550K | Sell |
7,602
-237
| -3% | -$16.8K | 0.13% | 140 |
|
|
2019
Q1 | $552K | Buy |
7,839
+40
| +0.5% | +$2.58K | 0.14% | 150 |
|
|
2018
Q4 | $520K | Buy |
7,799
+193
| +3% | +$12.1K | 0.14% | 156 |
|
|
2018
Q3 | $484K | Buy |
7,606
+158
| +2% | +$10.5K | 0.13% | 163 |
|
|
2018
Q2 | $497K | Sell |
7,448
-99
| -1% | -$6.48K | 0.13% | 170 |
|
|
2018
Q1 | $478K | Sell |
7,547
-793
| -10% | -$57.1K | 0.13% | 177 |
|
|
2017
Q4 | $586K | Buy |
8,340
+2,226
| +36% | +$163K | 0.17% | 146 |
|
|
2017
Q3 | $434K | Buy |
6,114
+310
| +5% | +$22.3K | 0.13% | 174 |
|
|
2017
Q2 | $415K | Hold |
5,804
| – | – | 0.13% | 183 |
|
|
2017
Q1 | $415K | Buy |
5,804
+128
| +2% | +$8.96K | 0.13% | 183 |
|
|
2016
Q4 | $417K | Buy |
5,676
+286
| +5% | +$19.6K | 0.13% | 186 |
|
|
2016
Q3 | $356K | Buy |
5,390
+13
| +0.2% | +$961 | 0.13% | 190 |
|
|
2016
Q2 | $402K | Buy |
5,377
+613
| +13% | +$43.6K | 0.14% | 168 |
|
|
2016
Q1 | $329K | Sell |
4,764
-2,382
| -33% | -$158K | 0.2% | 131 |
|
|
2015
Q4 | $462K | Buy |
7,146
+2,355
| +49% | +$157K | 0.3% | 106 |
|
|
2015
Q3 | $304K | Sell |
4,791
-12,210
| -72% | -$798K | 0.34% | 103 |
|
|
2015
Q2 | $1.11M | Buy |
17,001
+472
| +3% | +$32K | 1.72% | 22 |
|
|
2015
Q1 | $1.15M | Sell |
16,529
-223
| -1% | -$15.4K | 1.75% | 28 |
|
|
2014
Q4 | $1.17M | Buy |
+16,752
| New | +$1.13M | 2.15% | 27 |
|
Other funds holding CL
HighPoint Advisor Group's CL Position: Q2 2026 in Review
HighPoint Advisor Group increased its Colgate-Palmolive (CL) stake by 0.03% in Q2 2026, buying an estimated $175 and bringing the position to 6,023 shares worth $552K. The position accounts for 0.02% of the portfolio, ranked #445.
HighPoint Advisor Group first reported a position in CL in Q4 2014 and has held it in 40 quarters since. The position peaked at $2.03M in Q2 2021. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.
- HighPoint Advisor Group held 6,023 shares of Colgate-Palmolive worth $552K as of Q2 2026.
- HighPoint Advisor Group bought 2 Colgate-Palmolive shares in Q2 2026, an estimated $175.
- Colgate-Palmolive made up 0.02% of HighPoint Advisor Group's portfolio in Q2 2026, its #445 holding.
- HighPoint Advisor Group first reported a position in Colgate-Palmolive in Q4 2014 and has held it in 40 quarters since.
- HighPoint Advisor Group's Colgate-Palmolive position peaked at $2.03M in Q2 2021.
- 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.
Based on HighPoint Advisor Group's 13F filing for Q2 2026, filed 5 Aug 2026.